VIP (aviptadil) has no marketing authorisation from the FDA or EMA. Phase II studies have been conducted in sarcoidosis (20 patients, inhaled VIP) and pulmonary hypertension (8 patients, inhaled VI...
View full compound profile →Vendors stocking
4
across 2 countries
Total listings
4
4 in stock
Price range
£45.00–£69.00
Median price per mg
£13.80
Most common size
5mg
3 listings
Forms available
pre-mixed pen
Stock health
100%
4 vendors · 4 listings
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 4 vendor websites across 2 countries
